Share this Article
Singapore Med J 2014; 55(5): 271-280; http://dx.doi.org/10.11622/smedj.2014071
Vitamin D deficiency remains prevalent despite increased laboratory testing in New South Wales, Australia
Quaggiotto P, Tran H, Bhanugopan M
Correspondence: Dr Paul Quaggiotto, apollo13@netspace.net.au
ABSTRACT
INTRODUCTION The aim of the present study was to assess the prevalence of vitamin D deficiency and toxicity, the frequency of 25-hydroxyvitamin D (25[OH]D) testing, and 25(OH)D variations with respect to patient gender, patient age and season in New South Wales, Australia.
METHODS A retrospective analysis of pathology records was performed to ascertain patient age, patient gender, sample collection date, plasma or serum 25(OH)D levels, calcium and parathyroid hormone (PTH) levels, and test numbers between 2001 and 2010. Linear regression with Bonferroni correction was used to calculate and compare age-adjusted mean 25(OH)D levels. Relationships of 25(OH)D with PTH and calcium were tested using Spearman’s rank correlation.
RESULTS 25(OH)D testing increased by 730% over the ten-year study period. In 2010, many men (33%) and women (40%) were, to some degree, vitamin D deficient (≤ 50 nmol/L). Vitamin D toxicity was rare, with only one instance noted. 25(OH)D levels correlated positively with calcium and negatively with PTH levels. 25(OH)D levels decreased with age. In 2010, 25(OH)D levels were highest in February and lowest in September/October. Cyclical variation was observed for 25(OH)D levels between 2006 and 2010.
CONCLUSION We found that vitamin D deficiency was prevalent in both men and women, with a higher prevalence in the latter, despite the substantial increased demand for 25(OH)D testing in our population over the decade. Vitamin D deficiency was associated with elevated PTH levels. Vitamin D toxicity was rare and only observed once during our study period. 25(OH)D levels decreased with age and varied with season, with the highest levels observed in late summer and the lowest in early spring.
Keywords: 25-hydroxyvitamin D, age, calcium, deficiency, toxicity
Singapore Med J 2014; 55(5): 271-280; http://dx.doi.org/10.11622/smedj.2014071
REFERENCES
| 1. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006; 81:353-73. http://dx.doi.org/10.4065/81.3.353 | ||||
| 2. Stroud ML, Stilgoe S, Stott VE, Alhabian O, Salman K. Vitamin D - a review. Aust Fam Physician 2008; 37:1002-5. PMid:19142273 | ||||
| 3. Chen TC, Chimeh F, Lu Z, et al. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys 2007; 460:213-7. http://dx.doi.org/10.1016/j.abb.2006.12.017 | ||||
| 4. Omdahl JL, Morris HA, May BK. Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation. Annu Rev Nutr 2002; 22:139-66. http://dx.doi.org/10.1146/annurev.nutr.22.120501.150216 | ||||
| 5. Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 2004; 29:664-73. http://dx.doi.org/10.1016/j.tibs.2004.10.005 | ||||
| 6. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-81. http://dx.doi.org/10.1056/NEJMra070553 | ||||
| 7. Zerwekh JE. Blood biomarkers of vitamin D status. Am J Clin Nutr 2008; 87: 1087S-91S. PMid:18400739 | ||||
| 8. Shroff R, Knott C, Rees L. The virtues of vitamin D - but how much is too much? Pediatr Nephrol 2010; 25:1607-20. http://dx.doi.org/10.1007/s00467-010-1499-9 | ||||
| 9. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:1911-30. http://dx.doi.org/10.1210/jc.2011-0385 | ||||
| 10. Working Group of the Australian and New Zealand Bone and Mineral Society. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005; 182:281-5. PMid:15777143 | ||||
| 11. Hekimsoy Z, Dinç G, Kafesçiler S, et al. Vitamin D status among adults in the Aegean region of Turkey. BMC Public Health 2010; 10:782. http://dx.doi.org/10.1186/1471-2458-10-782 | ||||
| 12. Kuchuk NO, Pluijm SM, van Schoor NM, et al. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab 2009; 94:1244-50. http://dx.doi.org/10.1210/jc.2008-1832 | ||||
| 13. Billoo AG, Murtaza G, Memon MA, et al. Comparison of oral versus injectable vitamin-D for the treatment of nutritional vitamin D deficiency rickets. J Coll Physicians Surg Pak 2009; 19:428-31. PMid:19576150 | ||||
| 14. Lips P, van Schoor NM. The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab 2011; 25:585-91. http://dx.doi.org/10.1016/j.beem.2011.05.002 | ||||
| 15. Kendrick J, Targher G, Smits G, Chonchol M. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009; 205:255-60. http://dx.doi.org/10.1016/j.atherosclerosis.2008.10.033 | ||||
| 16. Williams S, Malatesta K, Norris K. Vitamin D and chronic kidney disease. Ethn Dis 2009; 19: S5-8-11. | ||||
| 17. Penckofer S, Kouba J, Wallis DE, Emanuele MA. Vitamin D and diabetes: let the sunshine in. Diabetes Educ 2008; 34:939-40. http://dx.doi.org/10.1177/0145721708326764 | ||||
| 18. Raghuwanshi A, Joshi SS, Christakos S. Vitamin D and multiple sclerosis. J Cell Biochem 2008; 105:338-43. http://dx.doi.org/10.1002/jcb.21858 | ||||
| 19. Lane NE. Vitamin D and systemic lupus erythematosus: bones, muscles, and joints. Curr Rheumatol Rep 2010; 12:259-63. http://dx.doi.org/10.1007/s11926-010-0106-1 | ||||
| 20. Rovner AJ, Stallings VA, Schall JI, Leonard MB, Zemel BS. Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation. Am J Clin Nutr 2007; 86:1694-9. PMid:18065588 | ||||
| 21. Jenab M, Bueno-de-Mesquita HB, Ferrari P, et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. BMJ 2010; 340:b5500. http://dx.doi.org/10.1136/bmj.b5500 | ||||
| 22. Engel P, Fagherazzi G, Boutten A, et al. Serum 25(OH) vitamin D and risk of breast cancer: a nested case-control study from the French E3N cohort. Cancer Epidemiol Biomarkers Prev 2010; 19:2341-50. http://dx.doi.org/10.1158/1055-9965.EPI-10-0264 | ||||
| 23. Choo CS, Mamedov A, Chung M, et al. Vitamin D insufficiency is common in patients with nonmetastatic prostate cancer. Nutr Res 2011; 31:21-6. http://dx.doi.org/10.1016/j.nutres.2010.12.007 | ||||
| 24. Heaney RP. Vitamin D: criteria for safety and efficacy. Nutr Rev 2008; 66:S178-81. http://dx.doi.org/10.1111/j.1753-4887.2008.00102.x | ||||
| 25. Nowson CA, McGrath JJ, Ebeling PR, et al. Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust 2012; 196:686-7. http://dx.doi.org/10.5694/mja11.10301 | ||||
| 26. Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 2007; 85:6-18. PMid:17209171 | ||||
| 27. Vieth R. Vitamin D and cancer mini-symposium: the risk of additional vitamin D. Ann Epidemiol 2009; 19:441-5. http://dx.doi.org/10.1016/j.annepidem.2009.01.009 | ||||
| 28. Vieth R. Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards. J Nutr 2006; 136:1117-22. PMid:16549491 | ||||
| 29. French D, Gorgi AW, Ihenetu KU, et al. Vitamin D status of county hospital patients assessed by the DiaSorin LIAISON® 25-hydroxyvitamin D assay. Clin Chim Acta 2011; 412:258-62. http://dx.doi.org/10.1016/j.cca.2010.10.013 | ||||
| 30. Bilinski K, Boyages S. The rise and rise of vitamin D testing. BMJ 2012; 345:e4743. http://dx.doi.org/10.1136/bmj.e4743 | ||||
| 31. Sattar N, Welsh P, Panarelli M, Forouhi NG. Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet 2012; 379:95-6. http://dx.doi.org/10.1016/S0140-6736(11)61816-3 | ||||
| 32. Kuriacose R, Olive KE. Prevalence of vitamin D deficiency and insufficiency in northeast Tennessee. South Med J 2008; 101:906-9. http://dx.doi.org/10.1097/SMJ.0b013e318181881b | ||||
| 33. Anderson JL, May HT, Horne BD, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010; 106:963-8. http://dx.doi.org/10.1016/j.amjcard.2010.05.027 | ||||
| 34. Bang UC, Semb S, Nordgaard-Lassen I, Jensen JE. A descriptive cross-sectional study of the prevalence of 25-hydroxyvitamin D deficiency and association with bone markers in a hospitalized population. Nutr Res 2009; 29:671-5. http://dx.doi.org/10.1016/j.nutres.2009.09.010 | ||||
| 35. Hirani V, Tull K, Ali A, Mindell J. Urgent action needed to improve vitamin D status among older people in England! Age Ageing 2010; 39:62-8. http://dx.doi.org/10.1093/ageing/afp195 PMid:19934073 | ||||
| 36. Houghton LA, Szymlek-Gay EA, Gray AR, et al. Predictors of vitamin D status and its association with parathyroid hormone in young New Zealand children. Am J Clin Nutr 2010; 92:69-76. http://dx.doi.org/10.3945/ajcn.2009.29055 | ||||
| 37. Schoenmakers I, Ginty F, Jarjou LM, et al. Interrelation of parathyroid hormone and vitamin D metabolites in adolescents from the UK and The Gambia. J Steroid Biochem Mol Biol 2010; 121:217-20. http://dx.doi.org/10.1016/j.jsbmb.2010.03.012 | ||||
| 38. Napiórkowska L, Budlewski T, Jakubas-Kwiatkowska W, et al. Prevalence of low serum vitamin D concentration in an urban population of elderly women in Poland. Pol Arch Med Wewn 2009; 119:699-703. PMid:19920793 | ||||
| 39. Hochwald O, Harman-Boehm I, Castel H. Hypovitaminosis D among inpatients in a sunny country. Isr Med Assoc J 2004; 6:82-7. PMid:14986463 | ||||
| 40. Grant WB, Cross HS, Garland CF, et al. Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe. Prog Biophys Mol Biol 2009; 99:104-13. http://dx.doi.org/10.1016/j.pbiomolbio.2009.02.003 | ||||
| 41. Grant WB, Schwalfenberg GK, Genuis SJ, Whiting SJ. An estimate of the economic burden and premature deaths due to vitamin D deficiency in Canada. Mol Nutr Food Res 2010; 54:1172-81. PMid:20352622 | ||||
| 42. Grant WB, Schuitemaker GE. Health benefits of higher serum 25-hydroxyvitamin D levels in The Netherlands. J Steroid Biochem Mol Biol 2010; 121:456-8. http://dx.doi.org/10.1016/j.jsbmb.2010.03.089 | ||||
| 43. Grant WB, Garland CF, Holick MF. Comparisons of estimated economic burdens due to insufficient solar ultraviolet irradiance and vitamin D and excess solar UV irradiance for the United States. Photochem Photobiol 2005; 81:1276-86. http://dx.doi.org/10.1562/2005-01-24-RA-424 | ||||
| 44. Kaptein S, Risselada AJ, Boerma EC, Egbers PH, Nieboer P. Life-threatening complications of vitamin D intoxication due to over-the-counter supplements. Clin Toxicol (Phila) 2010; 48:460-2. http://dx.doi.org/10.3109/15563650.2010.486382 | ||||
| 45. Klontz KC, Acheson DW. Dietary supplement-induced vitamin D intoxication. N Engl J Med 2007; 357:308-9. http://dx.doi.org/10.1056/NEJMc063341 | ||||
| 46. Johnson MA, Davey A, Park S, Hausman DB, Poon LW; Georgia Centenarian Study. Age, race and season predict vitamin D status in African American and white octogenarians and centenarians. J Nutr Health Aging 2008; 12:690-5. PMid:19043643 PMCid:PMC2978665 | ||||
| 47. Lanske B, Razzaque MS. Vitamin D and aging: old concepts and new insights. J Nutr Biochem 2007; 18:771-7. http://dx.doi.org/10.1016/j.jnutbio.2007.02.002 | ||||
| 48. Bruyere O, Decock C, Delhez M, Collette J, Reginster JY. Highest prevalence of vitamin D inadequacy in institutionalized women compared with noninstitutionalized women: a case-control study. Womens Health (Lond Engl) 2009; 5:49-54. http://dx.doi.org/10.2217/17455057.5.1.49 | ||||
| 49. Munns C, Zacharin MR, Rodda CP, et al. Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement. Med J Aust 2006; 185:268-72. PMid:16948623 | ||||
| 50. Wolpowitz D, Gilchrest BA. The vitamin D questions: how much do you need and how should you get it? J Am Acad Dermatol 2006; 54:301-17. http://dx.doi.org/10.1016/j.jaad.2005.11.1057 | ||||
| 51. Huotari A, Herzig KH. Vitamin D and living in northern latitudes--an endemic risk area for vitamin D deficiency. Int J Circumpolar Health 2008; 67:164-78. http://dx.doi.org/10.3402/ijch.v67i2-3.18258 | ||||
| 52. Pasco JA, Henry MJ, Kotowicz MA, et al. Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study. J Bone Miner Res 2004; 19:752-8. http://dx.doi.org/10.1359/jbmr.040125 | ||||
| 53. Brustad M, Edvardsen K, Wilsgaard T, et al. Seasonality of UV-radiation and vitamin D status at 69 degrees north. Photochem Photobiol Sci 2007; 6:903-8. http://dx.doi.org/10.1039/b702947k | ||||
| 54. Maeda SS, Kunii IS, Hayashi LF, Lazaretti-Castro M. Increases in summer serum 25-hydroxyvitamin D (25OHD) concentrations in elderly subjects in São Paulo, Brazil vary with age, gender and ethnicity. BMC Endocr Disord 2010; 10:12. http://dx.doi.org/10.1186/1472-6823-10-12 | ||||
| 55. Saliba W, Rennert HS, Kershenbaum A, Rennert G. Serum 25(OH)D concentrations in sunny Israel. Osteoporos Int 2012; 23:687-94. http://dx.doi.org/10.1007/s00198-011-1597-y | ||||